Microtubules and their role in cellular stress in cancer

Frontiers in Oncology

Volumn 4 JUN, Issue , 2014, Pages

  Parker, Amelia L ^a   Kavallaris, Maria ^a,b   McCarroll, Joshua A ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Microtubule associated proteins; microtubules; Post translational modifications; Stress response; Tubulin

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; BIM PROTEIN; CHAPERONE; DOCETAXEL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; PLATINUM; PROTEIN BCL 2; PROTEIN P53; TAU PROTEIN; TAXANE DERIVATIVE;

APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL HYPOXIA; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CELL STRESS; CELLULAR STRESS RESPONSE; CELLULAR STRESS SIGNAL; ENDOMETRIUM CARCINOMA; HUMAN; LUNG NON SMALL CELL CANCER; MACROAUTOPHAGY; METABOLIC REGULATION; METABOLIC STRESS; MICROTUBULE; MITOSIS INHIBITION; NEOPLASM; NUCLEOTIDE SEQUENCE; OVARY CANCER; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; STOMACH CANCER;

EID: 84904628230     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00153     Document Type: Review

References (253)

1. Nogales E. Structural insights into microtubule function. Annu Rev Biochem (2000) 69:277-302. doi: 10.1146/annurev.biochem.69.1.277
2. Downing KH, Nogales E. Tubulin structure: insights into microtubule properties and functions. Curr Opin Struct Biol (1998) 8(6):785-91. doi:10.1016/S0959-440X(98)80099-7
3. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer (2004) 4(4):253-65. doi:10.1038/nrc1317
4. Veldhoen RA, Banman SL, Hemmerling DR, Odsen R, Simmen T, Simmonds AJ, et al. The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis. Oncogene (2013) 32(6):736-46. doi:10.1038/onc.2012.92
5. Wang J, Yin YC, Hua H, Li MJ, Luo T, Xu L, et al. Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response. J Cell Mol Med (2009) 13(9B):3888-97. doi:10.1111/j.1582-4934.2009.00873.x
6. Xi GM, Hu XY, Wu BL, Jiang HM, Young CY, Pang YX, et al. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett (2011) 307(2):141-8. doi:10.1016/j.canlet.2011.03.026
7. Luduena RF. Are tubulin isotypes functionally significant. Mol Biol Cell (1993) 4(5):445-57. doi:10.1091/mbc.4.5.445
8. Sullivan KF, Cleveland DW. Identification of conserved isotype-defining variable region sequences for 4 vertebrate beta-tubulin polypeptide classes. Proc Natl Acad Sci U S A (1986) 83(12):4327-31. doi:10.1073/pnas.83.12.4327
9. Janke C, Bulinski JC. Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat Rev Mol Cell Biol (2011) 12(12):773-86. doi:10.1038/nrm3227
10. Kavallaris M, Tait AS, Walsh BJ, He LF, Horwitz SB, Norris MD, et al. Multiple microtubule alterations are associated with vinca alkaloid resistance in human leukemia cells. Cancer Res (2001) 61(15):5803-9.
11. Martello LA, Verdier-Pinard P, Shen HJ, He LF, Torres K, Orr GA, et al. Elevated levels of microtubule destabilizing factors in a taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation. Cancer Res (2003) 63(6):1207-13.
12. Verdier-Pinard P, Wang F, Martello L, Burd B, Orr GA, Horwitz SB. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry. Biochemistry (2003) 42(18):5349-57. doi:10.1021/bi027293o
13. Mozzetti S, Ferlini C, Concolino P, Filippetti F, Raspaglio G, Prislei S, et al. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res (2005) 11(1):298-305.
14. Sale S, Sung R, Shen PD, Yu K, Wang Y, Duran GE, et al. Conservation of the class I beta-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers. Mol Cancer Ther (2002) 1(3):215-25.
15. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer (2010) 10(3):194-204. doi:10.1038/nrc2803
16. Ferrandina G, Zannoni GF, Martinelli E, Paglia A, Gallotta V, Mozzetti S, et al. Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clin Cancer Res (2006) 12(9):2774-9. doi:10.1158/1078-0432.CCR-05-2715
17. Lee KM, Cao D, Itami A, Pour PM, Hruban RH, Maitra A, et al. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology (2007) 51(4):539-46. doi:10.1111/j.1365-2559.2007.02792.x
18. McCarroll JA, Gan PP, Liu M, Kavallaris M. Beta III-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer. Cancer Res (2010) 70(12):4995-5003. doi:10.1158/0008-5472.CAN-09-4487
19. Gan PP, McCarroll JA, Byrne FL, Garner J, Kavallaris M. Specific ß-tubulin isotypes can functionally enhance or diminish epothilone B sensitivity in non-small cell lung cancer cells. PLoS One (2011) 6(6):e21717. doi:10.1371/journal.pone.0021717
20. Gan PP, Kavallaris M. Tubulin-targeted drug action: functional significance of class II and class IVb beta-tubulin in vinca alkaloid sensitivity. Cancer Res (2008) 68(23):9817-24. doi:10.1158/0008-5472.CAN-08-1501
21. Cucchiarelli V, Hiser L, Smith H, Frankfurter A, Spano A, Correia JJ, et al. Beta-tubulin isotype classes II and V expression patterns in nonsmall cell lung carcinomas. Cell Motil Cytoskeleton (2008) 65(8):675-85. doi:10.1002/cm.20297
22. Don S, Verrills NM, Liaw TY, Liu ML, Norris MD, Haber M, et al. Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs. Mol Cancer Ther (2004) 3(9):1137-46.
23. Bhattacharya R, Cabral F. A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell (2004) 15(7):3123-31. doi:10.1091/mbc.E04-01-0060
24. Lobert S, Jefferson B, Morris K. Regulation of beta-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells. Cytoskeleton (Hoboken) (2011) 68(6):355-62. doi:10.1002/cm.20517
25. Verrills NM, Walsh BJ, Cobon GS, Hains PG, Kavallaris M. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J Biol Chem (2003) 278(46):45082-93. doi:10.1074/jbc.M303378200
26. Mozzetti S, Iantomasi R, De Maria I, Prislei S, Mariani M, Camperchioli A, et al. Molecular mechanisms of patupilone resistance. Cancer Res (2008) 68(24):10197-204. doi:10.1158/0008-5472.CAN-08-2091
27. Dozier JH, Hiser L, Davis JA, Thomas NS, Tucci MA, Benghuzzi HA, et al. Beta class II tubulin predominates in normal and tumor breast tissues. Breast Cancer Res (2003) 5(5):R157-69. doi:10.1186/bcr631
28. Blade K, Menick DR, Cabral F. Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to paclitaxel. J Cell Sci (1999) 112(13):2213-21.
29. Ranganathan S, McCauley RA, Dexter DW, Hudes GR. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III) cDNA transfection into prostate carcinoma cells. Br J Cancer (2001) 85(5):735-40. doi:10.1054/bjoc.2001.1956
30. Hari M, Yang H, Zeng C, Canizales M, Cabral F. Expression of class III ß-tubulin reduces microtubule assembly and confers resistance to paclitaxel. Cell Motil Cytoskeleton (2003) 56(1):45-56. doi:10.1002/cm.10132
31. Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, et al. High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Mol Cancer Ther (2012) 11(5):1203-13. doi:10.1158/1535-7163.MCT-11-0899
32. Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK, Richer JK. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther (2009) 8(5):1055-66. doi:10.1158/1535-7163.MCT-08-1046
33. Leskela S, Leandro-Garcia LJ, Mendiola M, Barriuso J, Inglada-Perez L, Munoz I, et al. The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients. Endocr Relat Cancer (2011) 18(1):85-95. doi:10.1677/ERC-10-0148
34. Akasaka K, Maesawa C, Shibazaki M, Maeda F, Takahashi K, Akasaka T, et al. Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells. J Invest Dermatol (2009) 129(6):1516-26. doi:10.1038/jid.2008.406
35. Izutsu N, Maesawa C, Shibazaki M, Oikawa H, Shoji T, Sugiyama T, et al. Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells. Int J Oncol (2008) 32(6):1227-35.
36. Tsourlakis MC, Weigand P, Grupp K, Kluth M, Steurer S, Schlomm T, et al. ßIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion. Am J Pathol (2014) 184(3):609-17. doi:10.1016/j.ajpath.2013.11.007
37. Ranganathan S, Dexter DW, Benetatos CA, Hudes GR. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochim Biophys Acta (1998) 1395(2):237-45. doi:10.1016/S0167-4781(97)00168-1
38. Saussede-Aim J, Matera EL, Herveau S, Rouault JP, Ferlini C, Dumontet C. Vinorelbine induces beta 3-tubulin gene expression through an AP-1 site. Anticancer Res (2009) 29(8):3003-9.
39. Raspaglio G, Filippetti F, Prislei S, Penci R, De Maria I, Cicchillitti L, et al. Hypoxia induces class III beta-tubulin gene expression by HIF-1 alpha binding to its 3' flanking region. Gene (2008) 409(1-2):100-8. doi:10.1016/j.gene.2007.11.015
40. Raspaglio G, De Maria I, Filippetti F, Martinelli E, Zannoni GF, Prislei S, et al. HuR regulates beta-tubulin isotype expression in ovarian cancer. Cancer Res (2010) 70(14):5891-900. doi:10.1158/0008-5472.CAN-09-4656
41. Masuda K, Abdelmohsen K, Gorospe M. RNA-binding proteins implicated in the hypoxic response. J Cell Mol Med (2009) 13(9A):2759-69. doi:10.1111/j.1582-4934.2009.00842.x
42. Schwarz PM, Liggins JR, Luduena RF. Beta-tubulin isotypes purified from bovine brain have different relative stabilities. Biochemistry (1998) 37(13):4687-92. doi:10.1021/bi972763d
43. Boekelheide K, Arcila ME, Eveleth J. Cis-diamminedichloroplatinum (ii) (cisplatin) alters microtubule assembly dynamics. Toxicol Appl Pharmacol (1992) 116(1):146-51. doi:10.1016/0041-008X(92)90156-M
44. Gan PP, McCarroll JA, Po'uha ST, Kamath K, Jordan MA, Kavallaris M. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of beta III-tubulin. Mol Cancer Ther (2010) 9(5):1339-48. doi:10.1158/1535-7163.MCT-09-0679
45. Kumar N, Flavin M. Preferential action of a brain detyrosinolating carboxypeptidase on polymerized tubulin. J Biol Chem (1981) 256(14):7678-86.
46. Peris L, Wagenbach M, Lafanechere L, Brocard J, Moore AT, Kozielski F, et al. Motor-dependent microtubule disassembly driven by tubulin tyrosination. J Cell Biol (2009) 185(7):1159-66. doi:10.1083/jcb.200902142
47. Soucek K, Kamaid A, Phung AD, Kubala L, Bulinski JC, Harper RW, et al. Normal and prostate cancer cells display distinct molecular profiles of a-tubulin posttranslational modifications. Prostate (2006) 66(9):954-65. doi:10.1002/pros.20416
48. Mialhe A, Lafanechere L, Treilleux I, Peloux N, Dumontet C, Bremond A, et al. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Res (2001) 61(13):5024-7.
49. Lafanechere L, Courtay-Cahen C, Kawakami T, Jacrot M, Rudiger M, Wehland J, et al. Suppression of tubulin tyrosine ligase during tumor growth. J Cell Sci (1998) 111:171-81.
50. Kato C, Miyazaki K, Nakagawa A, Ohira M, Nakamura Y, Ozaki T, et al. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis. Int J Cancer (2004) 112(3):365-75. doi:10.1002/ijc.20431
51. Whipple RA, Matrone MA, Cho EH, Balzer EM, Vitolo MI, Yoon JR, et al. Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement. Cancer Res (2010) 70(20):8127-37. doi:10.1158/0008-5472.CAN-09-4613
52. Giustiniani J, Daire V, Cantaloube I, Durand G, Poüs C, Perdiz D, et al. Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53. Cell Signal (2009) 21(4):529-39. doi:10.1016/j.cellsig.2008.12.004
53. Zhang ZH, Yamashita H, Toyama T, Sugiura H, Omoto Y, Ando Y, et al. HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res (2004) 10(20):6962-8. doi:10.1158/1078-0432.CCR-04-0455
54. Li WB, Zhang B, Tang JH, Cao Q, Wu YJ, Wu C, et al. Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J Neurosci (2007) 27(10):2606-16. doi:10.1523/JNEUROSCI.4181-06.2007
55. Ng F, Tang BL. Sirtuins' modulation of autophagy. J Cell Physiol (2013) 228(12):2262-70. doi:10.1002/jcp.24399
56. Tran AD, Marmo TP, Salam AA, Che S, Finkelstein E, Kabarriti R, et al. HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions. J Cell Sci (2007) 120(8):1469-79. doi:10.1242/jcs.03431
57. Gao YS, Hubbert CC, Yao TP. The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation. J Biol Chem (2010) 285(15):11219-26. doi:10.1074/jbc.M109.042754
58. Friedman JR, Webster BM, Mastronarde DN, Verhey KJ, Voeltz GK. ER sliding dynamics and ER-mitochondrial contacts occur on acetylated microtubules. J Cell Biol (2010) 190(3):363-75. doi:10.1083/jcb.200911024
59. Daire V, Giustiniani J, Leroy-Gori I, Quesnoit M, Drevensek S, Dimitrov A, et al. Kinesin-1 regulates microtubule dynamics via a c-Jun N-terminal kinase-dependent mechanism. J Biol Chem (2009) 284(46):31992-2001. doi:10.1074/jbc.M109.007906
60. Miller LM, Menthena A, Chatterjee C, Verdier-Pinard P, Novikoff PM, Horwitz SB, et al. Increased levels of a unique post-translationally modified ßIVb-tubulin isotype in liver cancer. Biochemistry (2008) 47(28):7572-82. doi:10.1021/bi8005225
61. Wasylyk C, Zambrano A, Zhao C, Brants J, Abecassis J, Schalken JA, et al. Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy. Int J Cancer (2010) 127(11):2542-53. doi:10.1002/ijc.25261
62. Bhat KM, Setaluri V. Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res (2007) 13(10):2849-54. doi:10.1158/1078-0432.CCR-06-3040
63. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, et al. Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A (2005) 102(23):8315-20. doi:10.1073/pnas.0408974102
64. Soltani MH, Pichardo R, Song ZQ, Sangha N, Camacho F, Satyamoorthy K, et al. Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma. Am J Pathol (2005) 166(6):1841-50. doi:10.1016/S0002-9440(10)62493-5
65. Song ZQ, He CD, Sun CK, Xu YN, Jin X, Zhang Y, et al. Increased expression of MAP2 inhibits melanoma cell proliferation, invasion and tumor growth in vitro and in vivo. Exp Dermatol (2010) 19(11):958-64. doi:10.1111/j.1600-0625.2009.01020.x
66. Verrills NM, Flemming CL, Liu M, Ivery MT, Cobon GS, Norris MD, et al. Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions. Chem Biol (2003) 10(7):597-607. doi:10.1016/S1074-5521(03)00141-8
67. Sun X, Li D, Yang Y, Ren Y, Li J, Wang Z, et al. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity. J Pathol (2012) 226(4):666-73. doi:10.1002/path.3026
68. Byrne FL, Yang L, Phillips PA, Hansford LM, Fletcher JI, Ormandy CJ, et al. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model. Oncogene (2014) 33(7):882-90. doi:10.1038/onc.2013.11
69. Rath O, Kozielski F. Kinesins and cancer. Nat Rev Cancer (2012) 12(8):527-39. doi:10.1038/nrc3310
70. Sirajuddin M, Rice LM, Vale RD. Regulation of microtubule motors by tubulin isotypes and post-translational modifications. Nat Cell Biol (2014) 16(4):335-44. doi:10.1038/ncb2920
71. LaPointe NE, Morfini G, Brady ST, Feinstein SC, Wilson L, Jordan MA. Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy. Neurotoxicology (2013) 37(0):231-9. doi:10.1016/j.neuro.2013.05.008
72. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene (2007) 26(22):3279-90. doi:10.1038/sj.onc.1210421
73. Reszka AA, Seger R, Diltz CD, Krebs EG, Fischer EH. Association of mitogen-activated protein-kinase with the microtubule cytoskeleton. Proc Natl Acad Sci U S A (1995) 92(19):8881-5. doi:10.1073/pnas.92.19.8881
74. Zhou J, Gupta K, Yao J, Ye KQ, Panda D, Giannakakou P, et al. Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine. J Biol Chem (2002) 277(42):39777-85. doi:10.1074/jbc.M203927200
75. Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, et al. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem (1999) 274(12):8208-16. doi:10.1074/jbc.274.12.8208
76. Seidman R, Gitelman I, Sagi O, Horwitz SB, Wolfson M. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells. Exp Cell Res (2001) 268(1):84-92. doi:10.1006/excr.2001.5262
77. Geeraert C, Ratier A, Pfisterer SG, Perdiz D, Cantaloube I, Rouault A, et al. Starvation-induced hyperacetylation of tubulin is required for the stimulation of autophagy by nutrient deprivation. J Biol Chem (2010) 285(31):24184-94. doi:10.1074/jbc.M109.091553
78. Tararuk T, Ostman N, Li WR, Bjorkblom B, Padzik A, Zdrojewska J, et al. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J Cell Biol (2006) 173(2):265-77. doi:10.1083/jcb.200511055
79. Chang LF, Jones Y, Ellisman MH, Goldstein LS, Karin M. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell (2003) 4(4):521-33. doi:10.1016/S1534-5807(03)00094-7
80. Fan M, Chambers TC. Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy. Drug Resist Updat (2001) 4(4):253-67. doi:10.1054/drup.2001.0214
81. Brantley-Finley C, Lyle CS, Du LH, Goodwin ME, Hall T, Szwedo D, et al. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol (2003) 66(3):459-69. doi:10.1016/S0006-2952(03)00255-7
82. Kolomeichuk SN, Terrano DT, Lyle CS, Sabapathy K, Chambers TC. Distinct signaling pathways of microtubule inhibitors - vinblastine and taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. FEBS J (2008) 275(8):1889-99. doi:10.1111/j.1742-4658.2008.06349.x
83. Hoshi M, Ohta K, Gotoh Y, Mori A, Murofushi H, Sakai H, et al. Mitogen-activated-protein-kinase-catalyzed phosphorylation of microtubule-associated proteins, microtubule-associated protein-2 and microtubule-associated protein-4, induces an alteration in their function. Eur J Biochem (1992) 203(1-2):43-52. doi:10.1111/j.1432-1033.1992.tb19825.x
84. Reszka AA, Bulinski JC, Krebs EG, Fischer EH. Mitogen-activated protein kinase extracellular signal-regulated kinase 2 regulates cytoskeletal organization and chemotaxis via catalytic and microtubule-specific interactions. Mol Biol Cell (1997) 8(7):1219-32. doi:10.1091/mbc.8.7.1219
85. Hu JY, Chu ZG, Han J, Dang YM, Yan H, Zhang Q, et al. The p38/MAPK pathway regulates microtubule polymerization through phosphorylation of MAP4 and Op18 in hypoxic cells. Cell Mol Life Sci (2010) 67(2):321-33. doi:10.1007/s00018-009-0187-z
86. Liu XM, Wang LG, Kreis W, Budman DR, Adams LM. Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells. Br J Cancer (2001) 85(9):1403-11. doi:10.1054/bjoc.2001.1910
87. Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu I, Blagosklonny MV, et al. Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci U S A (2002) 99(16):10855-60. doi:10.1073/pnas.132275599
88. Galigniana MD, Harrell JM, O'Hagen HM, Ljungman M, Pratt WB. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J Biol Chem (2004) 279(21):22483-9. doi:10.1074/jbc.M402223200
89. Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, Fojo T. p53 Is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol (2000) 2(10):709-17. doi:10.1038/35036335
90. Peng YH, Chen LH, Li CG, Lu WG, Chen JD. Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization. J Biol Chem (2001) 276(44):40583-90. doi:10.1074/jbc.M102817200
91. Kim JH, Yoon EK, Chung HJ, Park SY, Hong KM, Lee CH, et al. p53 Acetylation enhances taxol-induced apoptosis in human cancer cells. Apoptosis (2013) 18(1):110-20. doi:10.1007/s10495-012-0772-8
92. Lee SY, Kim JW, Jeong MH, An JH, Jang SM, Song KH, et al. Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells. FEBS Lett (2008) 582(19):2826-32. doi:10.1016/j.febslet.2008.07.021
93. Galmarini CM, Kamath K, Vanier-Viornery A, Hervieu V, Peiller E, Falette N, et al. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. Br J Cancer (2003) 88(11):1793-9. doi:10.1038/sj.bjc.6600960
94. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell (2003) 3(4):363-75. doi:10.1016/S1535-6108(03)00077-1
95. Obacz J, Pastorekova S, Vojtesek B, Hrstka R. Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses. Mol Cancer (2013) 12(1):93. doi:10.1186/1476-4598-12-93
96. Ivan M, Kondo K, Yang HF, Kim W, Valiando J, Ohh M, et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O-2 sensing. Science (2001) 292(5516):464-8. doi:10.1126/science.1059817
97. Fang YD, Xu X, Dang YM, Zhang YM, Zhang JP, Hu JY, et al. MAP4 mechanism that stabilizes mitochondrial permeability transition in hypoxia: microtubule enhancement and DYNLT1 interaction with VDAC1. PLoS One (2011) 6(12):e28052. doi:10.1371/journal.pone.0028052
98. Yoon SO, Shin S, Mercurio AM. Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha 6 beta 4 integrin. Cancer Res (2005) 65(7):2761-9. doi:10.1158/0008-5472.CAN-04-4122
99. Xu X, Zhang Q, Hu JY, Zhang DX, Jiang XP, Jia JZ, et al. Phosphorylation of DYNLT1 at serine 82 regulates microtubule stability and mitochondrial permeabilization in hypoxia. Mol Cells (2013) 36(4):322-32. doi:10.1007/s10059-013-0114-x
100. Hinman MN, Lou H. Diverse molecular functions of Hu proteins. Cell Mol Life Sci (2008) 65(20):3168-81. doi:10.1007/s00018-008-8252-6
101. Katsetos CD, Del Valle L, Geddes JF, Assimakopoulou M, Legido A, Boyd JC, et al. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas - a marker for anaplastic potential. Arch Pathol Lab Med (2001) 125(5):613-24.
102. Frew IJ, Smole Z, Thoma CR, Krek W. Genetic deletion of the long isoform of the von Hippel-Lindau tumour suppressor gene product alters microtubule dynamics. Eur J Cancer (2013) 49(10):2433-40. doi:10.1016/j.ejca.2013.02.024
103. Carbonaro M, Escuin D, O'Brate A, Thadani-Mulero M, Giannakakou P. Microtubules regulate hypoxia-inducible factor-1 alpha protein trafficking and activity implications for taxane therapy. J Biol Chem (2012) 287(15):11859-69. doi:10.1074/jbc.M112.345587
104. Carbonaro M, O'Brate A, Giannakakou P. Microtubule disruption targets HIF-1 alpha mRNA to cytoplasmic P-bodies for translational repression. J Cell Biol (2011) 192(1):83-99. doi:10.1083/jcb.201004145
105. Al-Mehdi AB, Pastukh VM, Swiger BM, Reed DJ, Patel MR, Bardwell GC, et al. Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci Signal (2012) 5(231):ra47. doi:10.1126/scisignal.2002712
106. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov (2013) 12(12):931-47. doi:10.1038/nrd4002
107. Cicchillitti L, Penci R, Di Michele M, Filippetti F, Rotilio D, Donati MB, et al. Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin. Mol Cancer Ther (2008) 7(7):2070-9. doi:10.1158/1535-7163.MCT-07-2370
108. Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, et al. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel. Lung Cancer (2009) 64(3):326-33. doi:10.1016/j.lungcan.2008.09.002
109. Joe PA, Banerjee A, Luduena RF. The roles of cys124 and ser239 in the functional properties of human beta III tubulin. Cell Motil Cytoskeleton (2008) 65(6):476-86. doi:10.1002/cm.20274
110. Eiserich JP, Estevez AG, Bamberg TV, Ye YZ, Chumley PH, Beckman JS, et al. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci U S A (1999) 96(11):6365-70. doi:10.1073/pnas.96.11.6365
111. Bisig CG, Purro SA, Contin MA, Barra HS, Arce CA. Incorporation of 3-nitrotyrosine into the C-terminus of alpha-tubulin is reversible and not detrimental to dividing cells. Eur J Biochem (2002) 269(20):5037-45. doi:10.1046/j.1432-1033.2002.03220.x
112. Cappelletti G, Maggioni MG, Ronchi C, Maci R, Tedeschi G. Protein tyrosine nitration is associated with cold- and drug-resistant microtubules in neuronal-like PC 12 cells. Neurosci Lett (2006) 401(1-2):159-64. doi:10.1016/j.neulet.2006.03.009
113. Fiore G, Di Cristo C, Monti G, Amoresano A, Columbano L, Pucci P, et al. Tubulin nitration in human gliomas. Neurosci Lett (2006) 394(1):57-62. doi:10.1016/j.neulet.2005.10.011
114. Kim JS, Lee JH, Jeong WW, Choi DH, Cha HJ, Kim DH, et al. Reactive oxygen species-dependent EndoG release mediates cisplatin-induced caspase-independent apoptosis in human head and neck squamous carcinoma cells. Int J Cancer (2008) 122(3):672-80. doi:10.1002/ijc.23158
115. Selimovic D, Hassan M, Haikel Y, Hengge UR. Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. Cell Signal (2008) 20(2):311-22. doi:10.1016/j.cellsig.2007.10.015
116. Alexandre J, Hu Y, Lu W, Pelicano H, Huang P. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res (2007) 67(8):3512-7. doi:10.1158/0008-5472.CAN-06-3914
117. Putnam AJ, Cunningham JJ, Pillemer BB, Mooney DJ. External mechanical strain regulates membrane targeting of Rho GTPases by controlling microtubule assembly. Am J Physiol Cell Physiol (2003) 284(3):C627-39. doi:10.1152/ajpcell.00137.2002
118. Cheng G, Diebold BA, Hughes Y, Lambeth JD. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem (2006) 281(26):17718-26. doi:10.1074/jbc.M512751200
119. Roediger B, Armati PJ. Oxidative stress induces axonal beading in cultured human brain tissue. Neurobiol Dis (2003) 13(3):222-9. doi:10.1016/S0969-9961(03)00038-X
120. Valen G, Sonden A, Vaage J, Malm E, Kjellstrom BT. Hydrogen peroxide induces endothelial cell atypia and cytoskeleton depolymerization. Free Radic Biol Med (1999) 26(11-12):1480-8. doi:10.1016/S0891-5849(99)00009-X
121. Hinshaw DB, Miller MT, Omann GM, Beals TF, Hyslop PA. A cellular-model of oxidant-mediated neuronal injury. Brain Res (1993) 615(1):13-26. doi:10.1016/0006-8993(93)91110-E
122. Stewart BJ, Doorn JA, Petersen DR. Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization. Chem Res Toxicol (2007) 20(8):1111-9. doi:10.1021/tx700106v
123. Neely MD, Boutte A, Milatovic D, Montine TJ. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res (2005) 1037(1-2):90-8. doi:10.1016/j.brainres.2004.12.027
124. Kokubo J, Nagatani N, Hiroki K, Kuroiwa K, Watanabe N, Arai T. Mechanism of destruction of microtubule structures by 4-hydroxy-2-nonenal. Cell Struct Funct (2008) 33(1):51-9. doi:10.1247/csf.07038
125. Divinski I, Holtser-Cochav M, Vulih-Schultzman I, Steingart RA, Gozes I. Peptide neuroprotection through specific interaction with brain tubulin. J Neurochem (2006) 98(3):973-84. doi:10.1111/j.1471-4159.2006.03936.x
126. Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol (2002) 156(6):1051-63. doi:10.1083/jcb.200108057
127. Altman BJ, Rathmell JC. Metabolic stress in autophagy and cell death pathways. Cold Spring Harb Perspect Biol (2012) 4(9):a008763. doi:10.1101/cshperspect.a008763
128. Saks VA, Kuznetsov AV, Khuchua ZA, Vasilyeva EV, Belikova JO, Kesvatera T, et al. Control of cellular respiration in-vivo by mitochondrial outer-membrane and by creatine-kinase - a new speculative hypothesis - possible involvement of mitochondrial-cytoskeleton interactions. J Mol Cell Cardiol (1995) 27(1):625-45. doi:10.1016/S0022-2828(08)80056-9
129. Bershadsky AD, Gelfand VI. ATP-dependent regulation of cytoplasmic microtubule disassembly. Proc Natl Acad Sci U S A (1981) 78(6):3610-3. doi:10.1073/pnas.78.6.3610
130. Infante AS, Stein MS, Zhai Y, Borisy GG, Gundersen GG. Detyrosinated (Glu) microtubules are stabilized by an ATP-sensitive plus-end cap. J Cell Sci (2000) 113(22):3907-19.
131. Marcussen M, Larsen PJ. Cell cycle-dependent regulation of cellular ATP concentration, and depolymerization of the interphase microtubular network induced by elevated cellular ATP concentration in whole fibroblasts. Cell Motil Cytoskeleton (1996) 35(2):94-9. doi:10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I
132. Nakano A, Kato H, Watanabe T, Min KD, Yamazaki S, Asano Y, et al. AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol (2010) 12(6):583-U139. doi:10.1038/ncb2060
133. Williams T, Courchet J, Viollet B, Brenman JE, Polleux F. AMP-activated protein kinase (AMPK) activity is not required for neuronal development but regulates axogenesis during metabolic stress. Proc Natl Acad Sci U S A (2011) 108(14):5849-54. doi:10.1073/pnas.1013660108
134. Tuerk RD, Thali RF, Auchli Y, Rechsteiner H, Brunisholz RA, Schlattner U, et al. New candidate targets of AMP-activated protein kinase in murine brain revealed by a novel multidimensional substrate-screen for protein kinases. J Proteome Res (2007) 6(8):3266-77. doi:10.1021/pr070160a
135. Sheldon KL, Maldonado EN, Lemasters JJ, Rostovtseva TK, Bezrukov SM. Phosphorylation of voltage-dependent anion channel by serine/threonine kinases governs its interaction with tubulin. PLoS One (2011) 6(10):e25539. doi:10.1371/journal.pone.0025539
136. Rostovtseva TK, Sheldon KL, Hassanzadeh E, Monge C, Saks V, Bezrukov SM, et al. Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration. Proc Natl Acad Sci U S A (2008) 105(48):18746-51. doi:10.1073/pnas.0806303105
137. Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C, et al. Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem (2002) 277(37):33664-9. doi:10.1074/jbc.M203834200
138. Maldonado EN, Sheldon KL, DeHart DN, Patnaik J, Manevich Y, Townsend DM, et al. Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells: regulation by free tubulin and erastin. J Biol Chem (2013) 288(17):11920-9. doi:10.1074/jbc.M112.433847
139. Vertessy BG, Bankfalvi D, Kovacs J, Low P, Lehotzky A, Ovadi J. Pyruvate kinase as a microtubule destabilizing factor in vitro. Biochem Biophys Res Commun (1999) 254(2):430-5. doi:10.1006/bbrc.1998.9957
140. Orosz F, Santamaria B, Ovadi J, Aragon JJ. Phosphofructokinase from Dictyostelium discoideum is a potent inhibitor of tubulin polymerization. Biochemistry (1999) 38(6):1857-65. doi:10.1021/bi981350p
141. Marmillot P, Keith T, Srivastava DK, Knull HR. Effect of tubulin on the activity of the muscle isoenzyme of lactate-dehydrogenase. Arch Biochem Biophys (1994) 315(2):467-72. doi:10.1006/abbi.1994.1526
142. Volker KW, Knull HR. A glycolytic enzyme binding domain on tubulin. Arch Biochem Biophys (1997) 338(2):237-43. doi:10.1006/abbi.1996.9819
143. Muronetz VI, Wang ZX, Keith TJ, Knull HR, Srivastava DK. Binding constants and stoichiometries of glyceraldehyde-3-phosphate dehydrogenase-tubulin complexes. Arch Biochem Biophys (1994) 313(2):253-60. doi:10.1006/abbi.1994.1385
144. Durrieu C, Berniervalentin F, Rousset B. Microtubules bind glyceraldehyde-3-phosphate dehydrogenase and modulate its enzyme-activity and quaternary structure. Arch Biochem Biophys (1987) 252(1):32-40. doi:10.1016/0003-9861(87)90005-1
145. Tisdale EJ, Kelly C, Artalejo CR. Glyceraldehyde-3-phosphate dehydrogenase interacts with Rab2 and plays an essential role in endoplasmic reticulum to Golgi transport exclusive of its glycolytic activity. J Biol Chem (2004) 279(52):54046-52. doi:10.1074/jbc.M409472200
146. Aon MA, Cortassa S. Coherent and robust modulation of a metabolic network by cytoskeletal organization and dynamics. Biophys Chem (2002) 97(2-3):213-31. doi:10.1016/S0301-4622(02)00056-X
147. Zala D, Hinckelmann MV, Yu H, da Cunha MM, Liot G, Cordelieres FP, et al. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell (2013) 152(3):479-91. doi:10.1016/j.cell.2012.12.029
148. Glaser PE, Han XL, Gross RW. Tubulin is the endogenous inhibitor of the glyceraldehyde 3-phosphate dehydrogenase isoform that catalyzes membrane fusion: implications for the coordinated regulation of glycolysis and membrane fusion. Proc Natl Acad Sci U S A (2002) 99(22):14104-9. doi:10.1073/pnas.222542999
149. Tisdale EJ, Azizi F, Artalejo CR. Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase c iota to associate with microtubules and to recruit dynein. J Biol Chem (2009) 284(9):5876-84. doi:10.1074/jbc.M807756200
150. Cueille N, Blanc CT, Riederer IM, Riederer BM. Microtubule-associated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase. J Proteome Res (2007) 6(7):2640-7. doi:10.1021/pr070081z
151. Kovacs J, Low P, Pacz A, Horvath I, Olah J, Ovadi J. Phosphoenolpyruvate-dependent tubulin-pyruvate kinase interaction at different organizational levels. J Biol Chem (2003) 278(9):7126-30. doi:10.1074/jbc.M210244200
152. Brinkley BR, Barham SS, Barranco SC, Fuller GM. Rotenone inhibition of spindle microtubule assembly in mammalian-cells. Exp Cell Res (1974) 85(1):41-6. doi:10.1016/0014-4827(74)90210-9
153. Dodson M, Darley-Usmar V, Zhang JH. Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic Biol Med (2013) 63:207-21. doi:10.1016/j.freeradbiomed.2013.05.014
154. Jin SK, White E. Role of autophagy in cancer - management of metabolic stress. Autophagy (2007) 3(1):28-31.
155. Xie R, Wang F, McKeehan WL, Liu LY. Autophagy enhanced by microtubule- and mitochondrion-associated MAP1S suppresses genome instability and hepatocarcinogenesis. Cancer Res (2011) 71(24):7537-46. doi:10.1158/0008-5472.CAN-11-2170
156. Guo JY, Xia B, White E. Autophagy-mediated tumor promotion. Cell (2013) 155(6):1216-9. doi:10.1016/j.cell.2013.11.019
157. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 4:e838. doi:10.1038/cddis.2013.350
158. Macintosh RL, Ryan KM. Autophagy in tumour cell death. Semin Cancer Biol (2013) 23(5):344-51. doi:10.1016/j.semcancer.2013.05.006
159. Amenta JS, Sargus MJ, Baccino FM. Effect of microtubular or translational inhibitors on general cell protein degradation - evidence for a dual catabolic pathway. Biochem J (1977) 168(2):223-7.
160. Fass E, Shvets E, Degani I, Hirschberg K, Elazar Z. Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes. J Biol Chem (2006) 281(47):36303-16. doi:10.1074/jbc.M607031200
161. Fengsrud M, Roos N, Berg T, Liou WL, Slot JW, Seglen PO. Ultrastructural and immunocytochemical characterization of autophagic vacuoles in isolated hepatocytes - effects of vinblastine and asparagine on vacuole distributions. Exp Cell Res (1995) 221(2):504-19. doi:10.1006/excr.1995.1402
162. Kochl R, Hu XW, Chan EY, Tooze SA. Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic (2006) 7(2):129-45. doi:10.1111/j.1600-0854.2005.00368.x
163. Webb JL, Ravikumar B, Rubinsztein DC. Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases. Int J Biochem Cell Biol (2004) 36(12):2541-50. doi:10.1016/j.biocel.2004.02.003
164. Acharya BR, Bhattacharyya S, Choudhury D, Chakrabarti G. The microtubule depolymerizing agent naphthazarin induces both apoptosis and autophagy in A549 lung cancer cells. Apoptosis (2011) 16(9):924-39. doi:10.1007/s10495-011-0613-1
165. Viola G, Bortolozzi R, Hamel E, Moro S, Brun P, Castagliuolo I, et al. MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells. Biochem Pharmacol (2012) 83(1):16-26. doi:10.1016/j.bcp.2011.09.017
166. Kouno T, Mizuguchi M, Tanida I, Ueno T, Kanematsu T, Mori Y, et al. Solution structure of microtubule-associated protein light chain 3 and identification of its functional subdomains. J Biol Chem (2005) 280(26):24610-7. doi:10.1074/jbc.M413565200
167. Liu LY, McKeehan WL, Wang F, Xie R. MAP1S enhances autophagy to suppress tumorigenesis. Autophagy (2012) 8(2):278-80. doi:10.4161/auto.8.2.18939
168. Xie R, Nguyen S, McKeehan K, Wang F, McKeehan WL, Liu LY. Microtubule-associated protein 1S (MAP1S) bridges autophagic components with microtubules and mitochondria to affect autophagosomal biogenesis and degradation. J Biol Chem (2011) 286(12):10367-77. doi:10.1074/jbc.M110.206532
169. Di Bartolomeo S, Corazzari M, Nazio F, Oliverio S, Lisi G, Antonioli M, et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J Cell Biol (2010) 191(1):155-68. doi:10.1083/jcb.201002100
170. Luo SQ, Garcia-Arencibia M, Zhao R, Puri C, Toh PP, Sadiq O, et al. Bim inhibits autophagy by recruiting beclin 1 to microtubules. Mol Cell (2012) 47(3):359-70. doi:10.1016/j.molcel.2012.05.040
171. Chen JX, Sun YJ, Wang P, Long DX, Li W, Li L, et al. Induction of autophagy by TOCP in differentiated human neuroblastoma cells lead to degradation of cytoskeletal components and inhibition of neurite outgrowth. Toxicology (2013) 310:92-7. doi:10.1016/j.tox.2013.05.012
172. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell (2010) 141(2):290-303. doi:10.1016/j.cell.2010.02.024
173. Korolchuk VI, Saiki S, Lichtenberg M, Siddiqi FH, Roberts EA, Imarisio S, et al. Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol (2011) 13(4):453-U242. doi:10.1038/ncb2204
174. Wei YJ, Pattingre S, Sinha S, Bassik M, Levine B. JNK1-mediated phosphorylation of BcI-2 regulates starvation-induced autophagy. Mol Cell (2008) 30(6):678-88. doi:10.1016/j.molcel.2008.06.001
175. Mochizuki Y, Ohashi R, Kawamura T, Iwanari H, Kodama T, Naito M, et al. Phosphatidylinositol 3-phosphatase myotubularin-related protein 6 (MTMR6) is regulated by small GTPase Rab1B in the early secretory and autophagic pathways. J Biol Chem (2013) 288(2):1009-21. doi:10.1074/jbc.M112.395087
176. Yang JY, Yang WY. Bit-by-bit autophagic removal of parkin-labelled mitochondria. Nat Commun (2013) 4:2428. doi:10.1038/ncomms3428
177. Appaix F, Kuznetsov AV, Usson Y, Kay L, Andrienko T, Olivares J, et al. Possible role of cytoskeleton in intracellular arrangement and regulation of mitochondria. Exp Physiol (2003) 88(1):175-90. doi:10.1113/eph8802511
178. Terasaki M, Chen LB, Fujiwara K. Microtubules and the endoplasmic-reticulum are highly interdependent structures. J Cell Biol (1986) 103(4):1557-68. doi:10.1083/jcb.103.4.1557
179. Aplin A, Jasionowski T, Tuttle DL, Lenk SE, Dunn WA. Cytoskeletal elements are required for the formation and maturation of autophagic vacuoles. J Cell Physiol (1992) 152(3):458-66. doi:10.1002/jcp.1041520304
180. Reunanen H, Marttinen M, Hirsimaki P. Effects of griseofulvin and nocodazole on the accumulation of autophagic vacuoles in ehrlich ascites tumor-cells. Exp Mol Pathol (1988) 48(1):97-102. doi:10.1016/0014-4800(88)90048-2
181. Kimura S, Noda T, Yoshimori T. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct (2008) 33(1):109-22. doi:10.1247/csf.08005
182. Luo B, Lee AS. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene (2013) 32(7):805-18. doi:10.1038/onc.2012.130
183. Ma YJ, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer (2004) 4(12):966-77. doi:10.1038/nrc1505
184. Dong DZ, Ni M, Li JZ, Xiong SG, Ye W, Virrey JJ, et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res (2008) 68(2):498-505. doi:10.1158/0008-5472.CAN-07-2950
185. Reddy RK, Mao CH, Baumeister P, Austin RC, Kaufman RJ, Lee AS. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors - role of ATP binding site in suppression of caspase-7 activation. J Biol Chem (2003) 278(23):20915-24. doi:10.1074/jbc.M212328200
186. Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, et al. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol (2013) 15(5):562-77. doi:10.1093/neuonc/not005
187. Yamada M, Tomida A, Yun JS, Cai B, Yoshikawa H, Taketani Y, et al. Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress. Cancer Chemother Pharmacol (1999) 44(1):59-64. doi:10.1007/s002800050945
188. Chatterjee S, Hirota H, Belfi CA, Berger SJ, Berger NA. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78. Cancer Res (1997) 57(22):5112-6.
189. Luvsandagva B, Nakamura K, Kitahara Y, Aoki H, Murata T, Ikeda S, et al. GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer. Gynecol Oncol (2012) 126(1):132-9. doi:10.1016/j.ygyno.2012.04.025
190. Li JZ, Lee AS. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med (2006) 6(1):45-54. doi:10.2174/156652406775574523
191. Liu JF, Fong YC, Chang KW, Kuo SC, Chang CS, Tang CH. FPTB, a novel CA-4 derivative, induces cell apoptosis of human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways. J Cell Biochem (2011) 112(2):453-62. doi:10.1002/jcb.22927
192. Bett JS, Ibrahim AF, Garg AK, Kelly V, Pedrioli P, Rocha S, et al. The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. Biochem J (2013) 451:185-94. doi:10.1042/BJ20130026
193. Chernov KG, Barbet A, Hamon L, Ovchinnikov LP, Curmi PA, Pastre D. Role of microtubules in stress granule assembly-microtubule dynamical instability favors the formation of micrometric stress granules in cells. J Biol Chem (2009) 284(52):36569-80. doi:10.1074/jbc.M109.042879
194. Anderson P, Kedersha N. RNA granules. J Cell Biol (2006) 172(6):803-8. doi:10.1083/jcb.200512082
195. Sriburi R, Jackowski S, Mori K, Brewer JW. XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J Cell Biol (2004) 167(1):35-41. doi:10.1083/jcb.200406136
196. Schuck S, Prinz WA, Thorn KS, Voss C, Walter P. Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response. J Cell Biol (2009) 187(4):525-36. doi:10.1083/jcb.200907074
197. Goyal U, Blackstone C. Untangling the web: mechanisms underlying ER network formation. Biochim Biophys Acta (2013) 1833(11):2492-8. doi:10.1016/j.bbamcr.2013.04.009
198. Waterman-Storer CM, Salmon ED. Microtubule dynamics: treadmilling comes around again. Curr Biol (1997) 7(6):R369-72. doi:10.1016/S0960-9822(06)00177-1
199. Lee C, Chen LB. Dynamic behavior of endoplasmic-reticulum in living cells. Cell (1988) 54(1):37-46. doi:10.1016/0092-8674(88)90177-8
200. Ogburn KD, Figueiredo-Pereira ME. Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates. J Biol Chem (2006) 281(32):23274-84. doi:10.1074/jbc.M600635200
201. Wettstein G, Bellaye PS, Micheau O, Bonniaud P. Small heat shock proteins and the cytoskeleton: an essential interplay for cell integrity? Int J Biochem Cell Biol (2012) 44(10):1680-6. doi:10.1016/j.biocel.2012.05.024
202. Ghosh JG, Houck SA, Clark JI. Interactive domains in the molecular chaperone human alpha B crystallin modulate microtubule assembly and disassembly. PLoS One (2007) 2(6):e498. doi:10.1371/journal.pone.0000498
203. Houck SA, Clark JI. Dynamic subunit exchange and the regulation of microtubule assembly by the stress response protein human alpha B crystallin. PLoS One (2010) 5(7):e11795. doi:10.1371/journal.pone.0011795
204. Fujita Y, Ohto E, Katayama E, Atomi Y. Alpha B-crystallin-coated MAP microtubule resists nocodazole and calcium-induced disassembly. J Cell Sci (2004) 117(9):1719-26. doi:10.1242/jcs.01021
205. Hino M, Kurogi K, Okubo MA, Murata-Hori M, Hosoya H. Small heat shock protein 27 (HSP27) associates with tubulin/microtubules in HeLa cells. Biochem Biophys Res Commun (2000) 271(1):164-9. doi:10.1006/bbrc.2000.2553
206. Almeida-Souza L, Asselbergh B, De Winter V, Goethals S, Timmerman V, Janssens S. HSPB1 facilitates the formation of non-centrosomal microtubules. PLoS One (2013) 8(6):e66541. doi:10.1371/journal.pone.0066541
207. Casado P, Zuazua-Villar P, Prado MA, del Valle E, Iglesias JM, Martinez-Campa C, et al. Characterization of HSP27 phosphorylation induced by microtubule interfering agents: implication of p38 signalling pathway. Arch Biochem Biophys (2007) 461(1):123-9. doi:10.1016/j.abb.2007.01.027
208. Sanchez C, Padilla R, Paciucci R, Zabala JC, Avila J. Binding of heat-shock protein-70 (hsp70) to tubulin. Arch Biochem Biophys (1994) 310(2):428-32. doi:10.1006/abbi.1994.1188
209. Welch WJ, Feramisco JR, Blose SH. The mammalian stress response and the cytoskeleton - alterations in intermediate filaments. Ann N Y Acad Sci (1985) 455:57-67. doi:10.1111/j.1749-6632.1985.tb50403.x
210. Selimovic D, Badura HE, El-Khattouti A, Soell M, Porzig B, Spernger A, et al. Vinblastine-induced apoptosis of melanoma cells is mediated by Ras homologous A protein (Rho A) via mitochondrial and non-mitochondrial-dependent mechanisms. Apoptosis (2013) 18(8):980-97. doi:10.1007/s10495-013-0844-4
211. Guo SH, Wharton W, Moseley P, Shi HL. Heat shock protein 70 regulates cellular redox status by modulating glutathione-related enzyme activities. Cell Stress Chaperones (2007) 12(3):245-54. doi:10.1379/CSC-265.1
212. Quintá HR, Galigniana NM, Erlejman AG, Lagadari M, Piwien-Pilipuk G, Galigniana MD. Management of cytoskeleton architecture by molecular chaperones and immunophilins. Cell Signal (2011) 23(12):1907-20. doi:10.1016/j.cellsig.2011.07.023
213. Hong DS, Banerji U, Tavana B, George GC, Aaron J, Kurzrock R. Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions. Cancer Treat Rev (2013) 39(4):375-87. doi:10.1016/j.ctrv.2012.10.001
214. Weis F, Moullintraffort L, Heichette C, Chretien D, Garnier C. The 90-kDa heat Shock protein Hsp90 protects tubulin against thermal denaturation. J Biol Chem (2010) 285(13):9525-34. doi:10.1074/jbc.M109.096586
215. Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (2003) 228(2):111-33.
216. Pratt WB, Morishima Y, Peng HM, Osawa Y. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Exp Biol Med (2010) 235(3):278-89. doi:10.1258/ebm.2009.009250
217. Rovini A, Savry A, Braguer D, Carre M. Microtubule-targeted agents: when mitochondria become essential to chemotherapy. Biochim Biophys Acta (2011) 1807(6):679-88. doi:10.1016/j.bbabio.2011.01.001
218. Ren Y, Zhao JH, Feng J. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J Neurosci (2003) 23(8):3316-24.
219. Jung D, Filliol D, Miehe M, Rendon A. Interaction of brain mitochondria with microtubules reconstituted from brain tubulin and MAP2 or Tau. Cell Motil Cytoskeleton (1993) 24(4):245-55. doi:10.1002/cm.970240405
220. Maldonado EN, Patnaik J, Mullins MR, Lemasters JJ. Free tubulin modulates mitochondrial membrane potential in cancer cells. Cancer Res (2010) 70(24):10192-201. doi:10.1158/0008-5472.CAN-10-2429
221. Guzun R, Karu-Varikmaa M, Gonzalez-Granillo M, Kuznetsov AV, Michel L, Cottet-Rousselle C, et al. Mitochondria-cytoskeleton interaction: distribution of beta-tubulins in cardiomyocytes and HL-1 cells. Biochim Biophys Acta (2011) 1807(4):458-69. doi:10.1016/j.bbabio.2011.01.010
222. Andre N, Braguer D, Brasseur G, Goncalves A, Lemesle-Meunier D, Guise S, et al. Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells. Cancer Res (2000) 60(19):5349-53.
223. Ferlini C, Raspaglio G, Mozzetti S, Distefano M, Filippetti F, Martinelli E, et al. Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance. Mol Pharmacol (2003) 64(1):51-8. doi:10.1124/mol.64.1.51
224. Gajate C, Barasoain I, Andreu JM, Mollinedo F. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by bcl-2 and bcl-x(L) and cell cycle arrest. Cancer Res (2000) 60(10):2651-9.
225. Ibrado AM, Liu L, Bhalla K. Bcl-x(L) overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res (1997) 57(6):1109-15.
226. Esteve MA, Carre M, Bourgarel-Rey V, Kruczynski A, Raspaglio G, Ferlini C, et al. Bcl-2 down-regulation and tubulin subtype composition are involved in resistance of ovarian cancer cells to vinflunine. Mol Cancer Ther (2006) 5(11):2824-33. doi:10.1158/1535-7163.MCT-06-0277
227. Knipling L, Wolff J. Direct interaction of Bcl-2 proteins with tubulin. Biochem Biophys Res Commun (2006) 341(2):433-9. doi:10.1016/j.bbrc.2005.12.201
228. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell (1999) 3(3):287-96. doi:10.1016/S1097-2765(00)80456-6
229. Giodini A, Kallio MJ, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res (2002) 62(9):2462-7.
230. Prislei S, Mozzetti S, Filippetti F, De Donato M, Raspaglio G, Cicchillitti L, et al. From plasma membrane to cytoskeleton: a novel function for semaphorin 6A. Mol Cancer Ther (2008) 7(1):233-41. doi:10.1158/1535-7163.MCT-07-0390
231. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol (1998) 18(6):3509-17.
232. Ling YH, Tornos C, Perez-Soler R. Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J Biol Chem (1998) 273(30):18984-91. doi:10.1074/jbc.273.30.18984
233. Verdier-Pinard P, Pasquier E, Xiao H, Burd B, Villard C, Lafitte D, et al. Tubulin proteomics: towards breaking the code. Anal Biochem (2009) 384(2):197-206. doi:10.1016/j.ab.2008.09.020
234. Hasegawa S, Miyoshi Y, Egawa C, Ishitobi M, Taguchi T, Tamaki Y, et al. Prediction of response to docetaxel by quantitative analysis of class I and III beta-tubulin isotype mRNA expression in human breast cancers. Clin Cancer Res (2003) 9(8):2992-7.
235. Zhang HL, Ruan L, Zheng LM, Whyte D, Tzeng CM, Zhou XW. Association between class III beta-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: a meta-analysis. Lung Cancer (2012) 77(1):9-15. doi:10.1016/j.lungcan.2012.01.005
236. Sève P, Lai R, Ding K, Winton T, Butts C, Mackey J, et al. Class III ß-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10. Clin Cancer Res (2007) 13(3):994-9. doi:10.1158/1078-0432.CCR-06-1503
237. Reiman T, Lai R, Veillard AS, Paris E, Soria JC, Rosell R, et al. Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials. Ann Oncol (2012) 23(1):86-U10. doi:10.1093/annonc/mdr033
238. Seve P, Isaac S, Tredan O, Souquet PJ, Pacheco Y, Perol M, et al. Expression of class III beta-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. Clin Cancer Res (2005) 11(15):5481-6. doi:10.1158/1078-0432.CCR-05-0285
239. Ohishi Y, Oda Y, Basaki Y, Kobayashi H, Wake N, Kuwano M, et al. Expression of beta-tubulin isotypes in human primary ovarian carcinoma. Gynecol Oncol (2007) 105(3):586-92. doi:10.1016/j.ygyno.2007.01.044
240. Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M, et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest (1997) 100(5):1282-93. doi:10.1172/JCI119642
241. De Donato M, Mariani M, Petrella L, Martinelli E, Zannoni GF, Vellone V, et al. Class III beta-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. J Cell Physiol (2012) 227(3):1034-41. doi:10.1002/jcp.22813
242. Su D, Smith SM, Preti M, Schwartz P, Rutherford TJ, Menato G, et al. Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel. Cancer (2009) 115(11):2453-63. doi:10.1002/cncr.24282
243. Aoki D, Oda Y, Hattori S, Taguchi K, Ohishi Y, Basaki Y, et al. Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma. Clin Cancer Res (2009) 15(4):1473-80. doi:10.1158/1078-0432.CCR-08-1274
244. Paradiso A, Mangia A, Chiriatti A, Tommasi S, Zito A, Latorre A, et al. Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer. Ann Oncol (2005) 16:14-9. doi:10.1093/annonc/mdi902
245. Portyanko A, Kovalev P, Gorgun J, Cherstvoy E. Beta(III)-tubulin at the invasive margin of colorectal cancer: possible link to invasion. Virchows Arch (2009) 454(5):541-8. doi:10.1007/s00428-009-0764-4
246. Roque DM, Bellone S, English DP, Buza N, Cocco E, Gasparrini S, et al. Tubulin-beta-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones. Cancer (2013) 119(14):2582-92. doi:10.1002/cncr.28017
247. Hwang JE, Hong JY, Kim K, Kim SH, Choi WY, Kim MJ, et al. Class III beta-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer. BMC Cancer (2013) 13:431. doi:10.1186/1471-2407-13-431
248. Ploussard G, Terry S, Maille P, Allory Y, Sirab N, Kheuang L, et al. Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy. Cancer Res (2010) 70(22):9253-64. doi:10.1158/0008-5472.CAN-10-1447
249. Terry S, Ploussard G, Allory Y, Nicolaiew N, Boissiere-Michot F, Maille P, et al. Increased expression of class III beta-tubulin in castration-resistant human prostate cancer. Br J Cancer (2009) 101(6):951-6. doi:10.1038/sj.bjc.6605245
250. Bernard-Marty C, Treilleux I, Dumontet C, Cardoso F, Fellous A, Gancberg D, et al. Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study. Clin Breast Cancer (2002) 3(5):341-5. doi:10.3816/CBC.2002.n.037
251. Christoph DC, Kasper S, Gauler TC, Loesch C, Engelhard M, Theegarten D, et al. BetaV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer. Br J Cancer (2012) 107(5):823-30. doi:10.1038/bjc.2012.324
252. Lu CH, Zhang J, He S, Wan CH, Shan AD, Wang YY, et al. Increased alpha-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma. Dig Dis Sci (2013) 58(9):2713-20. doi:10.1007/s10620-013-2692-z
253. Caracciolo V, D'Agostino L, Draberova E, Sladkova V, Crozier-Fitzgerald C, Agamanolis DP, et al. Differential expression and cellular distribution of gamma-tubulin and beta III-tubulin in medulloblastomas and human medulloblastoma cell lines. J Cell Physiol (2010) 223(2):519-29. doi:10.1002/jcp.22077